Ingredion reported weaker results for Q1 2026, with net income attributable to the company falling to $142 million from $197 million a year earlier. Net sales slipped 1% to $1.79 billion, while gross profit declined to $401 million and gross margin narrowed from 26% to 22% due mainly to lower volumes and fixed-cost absorption.
Operating income dropped 26% to $203 million as cost of sales rose and operating expenses increased 4% to $200 million on higher employee costs. Segment performance was mixed: Texture & Healthful Solutions and Latin America grew sales modestly, but U.S./Canada net sales fell 9% and operating income there dropped sharply to $34 million, reflecting production challenges at the Argo facility and softer volumes.
Cash from operating activities decreased to $33 million from $77 million, while capital spending rose to $110 million. The company highlighted strong liquidity of $3.8 billion and total debt of $1.8 billion. Subsequent to quarter end, Ingredion approved a plan to cease operations at its Cabo, Brazil facility and disclosed an Argo “thermal event,” expecting about $43 million of related pre-tax charges and roughly $20 million of direct costs, largely in Q2 2026.
Ingredion Inc executive Robert A. Ritchie reported a routine tax-withholding share disposition related to vesting equity awards. On this Form 4, 842 shares of common stock were withheld at $110.43 per share to cover taxes when 2,880 restricted stock units and 241.005 RSUs from deemed dividend reinvestments vested. Following this event, he directly holds 31,177.7458 common shares.
Ingredion Incorporated plans to cease operations at its Cabo, Brazil manufacturing facility as of June 30, 2026, and expects to sell the facility and underlying real property. The company anticipates approximately $43 million in pre-tax, non-recurring charges tied to this exit plan.
About $36 million of these charges are expected to be non-cash impairment charges related to fixed asset and inventory write-downs, with about $7 million in expected cash expenditures for employee-related, severance, and other termination costs. Most charges are expected in the second quarter of 2026, with remaining amounts through the first quarter of 2027.
Ingredion Incorporated reported weaker first quarter 2026 results, with earnings and operating profit declining year over year and full-year guidance reduced. Net sales were $1.792 billion, down 1% from $1.813 billion in the first quarter 2025 as softer demand and less favorable mix in Food & Industrial Ingredients–U.S./Canada more than offset growth in other segments.
Reported diluted EPS fell to $2.22 from $3.00, while adjusted EPS declined to $2.34 from $2.97, reflecting lower operating income and higher restructuring costs. Reported operating income dropped to $203 million from $276 million, and adjusted operating income decreased to $212 million from $273 million, driven mainly by higher costs and lower volumes in the U.S./Canada business, including production challenges at the Argo facility.
Texture & Healthful Solutions delivered continued volume growth, with operating income of $100 million, slightly above the prior year, and Food & Industrial Ingredients–LATAM posted operating income of $115 million, down from $127 million. All Other generated operating income of $3 million, reflecting improvements in plant-based protein.
The company updated its full-year 2026 outlook, now expecting reported EPS of $9.60–$10.30 and adjusted EPS of $10.45–$11.15. It now anticipates full-year net sales to be flat to up low single digits, reported operating income to be down high single digits, and adjusted operating income to be flat to down low single digits. For full-year 2026, Ingredion expects cash from operations of $725–$825 million and capital expenditures of $400–$440 million.
Ingredion Inc senior vice president David Eric Seip reported a compensation-related grant of phantom stock on April 30, 2026. He acquired 15.63 phantom stock units under the company’s Non-Qualified Deferred Compensation Plan, with each unit representing the right to receive one share of common stock.
Following this grant and prior allocations, Seip now has a total of 13,166.2221 phantom stock units credited under the plan, based on the issuer’s closing share price on April 30, 2026 and including units accumulated through dividend reinvestment.
Leonard Michael J reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc senior vice president and chief information officer Michael J. Leonard received a grant of 30.569 phantom stock units on April 30, 2026. These units were credited under the company’s Non-Qualified Deferred Compensation Plan based on the closing price of Ingredion common stock on that date.
Each phantom stock unit represents the right to receive one share of common stock in the future, and the total phantom stock balance for Leonard after this grant is 1,582.171 units, including amounts accumulated through dividend reinvestment.
Ingredion Inc ownership report: Vanguard Capital Management reported beneficial ownership of 3,293,051 shares of Common Stock, representing 5.23% of the class. The filing states Vanguard has sole dispositive power over 3,293,051 shares and sole voting power for 480,686 shares.
The report is a Schedule 13G disclosure by an institutional investor and describes holdings across affiliated Vanguard entities, with signatures executed 04/30/2026.
Ingredion Incorporated reports that First Trust Portfolios L.P., First Trust Advisors L.P. and The Charger Corporation jointly reported beneficial ownership of 3,972,425 shares of Common stock, representing 6.31% of the class. The filing states shared voting power of 3,371,328 and shared dispositive power of 3,972,425. The filing is submitted under Rule 13d-1(k)(1) as a joint filing and is signed by James M. Dykas on 04/30/2026.
Ingredion Inc reports that Vanguard Portfolio Management LLC beneficially owned 4,679,559 shares of Common Stock, representing 7.43% of the class as of 03/31/2026. The filing states Vanguard exercises sole dispositive power over 4,679,559 shares and sole voting power for 28,095 shares, and notes ownership is held on behalf of Vanguard funds and managed accounts.
Ingredion Inc director Stephan B. Tanda reported non-market transfers of common stock as bona fide gifts. On April 16, 2026, he reported two gift transactions totaling 760 shares of Ingredion common stock at a reported price of $0.00 per share. One transaction moved 380 directly owned shares to The Tanda Joint Living Trust, where he and his spouse serve as trustees and immediate family members are beneficiaries. After these transactions, 10,737 Ingredion shares are reported as held indirectly through this trust, with no remaining directly held shares shown.